Carbios has accelerated its enzyme screening process with a microfluidic technology developed in partnership with the Paul Pascal Research Centre.
Lucid Diagnostics Inc. announced that Dr. Lishan Aklog, Chairman and Chief Executive Officer; and Dennis McGrath, Chief Financial Officer will present at the 22nd Annual Needham Healthcare Conference on Thursday, April 20, 2023 at 11:00 AM ET.
Lucid Diagnostics to Present at 22nd Annual Needham Virtual Healthcare Conference Read More »
Transgene and NEC Corporation announced that new data will be presented on TG4050, an individualized neoantigen cancer vaccine, at the American Association for Cancer Research Annual Meeting in Orlando, Florida.
GC Genome Corporation, a leading diagnostics company, announced that the company will present data showcasing the deep learning algorithm that detects and classifies multi-cancer using methylation information and genomic data at the American Association for Cancer Research Annual Meeting 2023 in Orlando, Florida.
OSE Immunotherapeutics SA announces three presentations at the American Association for Cancer Research Annual Meeting in Orlando, April 14-19, 2023.
Glucose monitoring is a key link in diabetes management. Currently, there are two main methods for self-monitoring of glucose in patients with diabetes, one is the traditional blood glucose Monitoring, and the other is continuous glucose monitoring.
Sensorion a pioneering clinical-stage biotechnology company which specializes in gene therapies in the inner ear, is pleased to announce its participation in two investor conferences in April 2023.
Data of InnoCare’s robust oncology pipelines were presented at the 2023 American Association for Cancer Research Annual Meeting.
Data of InnoCare’s Robust Oncology Pipelines Presented at the 2023 AACR Annual Meeting Read More »
BerGenBio ASA announced that it presented data linking AXL activation to STK11 loss of function in Non-Small Cell Lung Cancer in an abstract titled, AXL as a Therapeutic Target in STK11 mutant NSCLC, at the American Association for Cancer Research Annual Meeting 2023.
BerGenBio Presents Data on STK11 Loss of Function and AXL Activation at AACR Read More »
Marlena Fejzo, una genetista que sufrió náuseas y vómitos intensos durante el embarazo, hizo de la búsqueda de la causa de su enfermedad la hiperémesis gravídica su misión de vida.
